Literature DB >> 19046480

Elevation of the index of left ventricular mass during the acute and subacute phase of Kawasaki disease, and its association with indexes of diastolic function.

Jeong J Yu1, Byung O Kwak, You H Jeon, Yong-Mean Park, Ran Lee, Sochung Chung, Sun H Bae, Bok Y Pyun.   

Abstract

Our aim was to determine whether the index of left ventricular mass increases during the acute and subacute phase of Kawasaki disease, and to investigate any relationship between this index and clinical and echocardiographic variables. We performed, therefore, a retrospective study of 66 children with Kawasaki disease, having a mean age of 2.85 years, comparing the findings with those obtained from 57 normal controls, having a mean age of 2.99 years. The data from the patients used for comparison was obtained during the acute and subacute phase of the illness, as well as during the phase of convalescence. We performed correlation analysis of the findings during the acute and subacute phase, determining the relationship between the index of left ventricular mass and other variables. The index was higher (p = 0.0461), and the velocity of propagation of left ventricular early diastolic flow was lower (p < 0.0001), during the acute and subacute phase when compared to control values. The index then reduced (p = 0.0001) during the phase of convalescent when compared to the acute and subacute phase. Levels of albumin in the serum (p = 0.0193), peak E velocity (p = 0.0479), and velocity of propagation (p = 0.0360) were found to be related to the index of left ventricular mass. Significant relationships were found between the differences in this index and differences in body weight when findings during the acute and subacute phase were compared to those of the phase of convalescence. The index of left ventricular mass, therefore, is increased during the acute and subacute phase of Kawasaki disease, and is associated with altered diastolic indexes. This elevation may be due to generalized myocardial swelling from acute inflammation and increased vascular permeability. Measuring this index as a potential predictor of diastolic function should be added to studies of cardiac function during the acute and subacute phase of Kawasaki disease.

Entities:  

Mesh:

Year:  2008        PMID: 19046480     DOI: 10.1017/S1047951108003405

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  10 in total

1.  Myocardial Layers Specific Strain Analysis for the Acute Phase of Infant Kawasaki Disease.

Authors:  Lucy Youngmin Eun; Ji Hong Kim; Jo Won Jung; Jae Young Choi
Journal:  Pediatr Cardiol       Date:  2016-07-09       Impact factor: 1.655

2.  Ventricular repolarisation during exercise challenge occurring late after Kawasaki disease.

Authors:  Hugo Gravel; Nagib Dahdah; Anne Fournier; Marie-Ève Mathieu; Daniel Curnier
Journal:  Pediatr Cardiol       Date:  2012-02-18       Impact factor: 1.655

3.  Analyses of left ventricular myocardial deformation by speckle-tracking imaging during the acute phase of Kawasaki disease.

Authors:  Jeong Jin Yu; Hyung Soon Choi; Yong Beom Kim; Jae Sung Son; Young-Hwue Kim; Jae-Kon Ko; In-Sook Park
Journal:  Pediatr Cardiol       Date:  2010-04-20       Impact factor: 1.655

4.  B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease.

Authors:  Satoru Iwashima; Takamichi Ishikawa
Journal:  World J Pediatr       Date:  2013-01-18       Impact factor: 2.764

5.  Log-transformed plasma level of brain natriuretic peptide during the acute phase of Kawasaki disease is quantitatively associated with myocardial dysfunction.

Authors:  Sunhee Bang; Jeong Jin Yu; Myung-Ki Han; Hong Ki Ko; Sail Chun; Hyung Soon Choi; Young-Hwue Kim; Jae-Kon Ko; In-Sook Park
Journal:  Korean J Pediatr       Date:  2011-08-31

6.  Diagnosis of incomplete Kawasaki disease.

Authors:  Jeong Jin Yu
Journal:  Korean J Pediatr       Date:  2012-03-16

7.  IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis.

Authors:  M Gorelik; Y Lee; M Abe; T Andrews; L Davis; J Patterson; S Chen; T R Crother; G J Aune; M Noval Rivas; M Arditi
Journal:  Clin Exp Immunol       Date:  2019-06-21       Impact factor: 4.330

8.  Evaluation of left ventricular function in immunoglobulin-resistant children with Kawasaki disease: a two-dimensional speckle tracking echocardiography study.

Authors:  Haiyong Wang; Jing Shang; Minghui Tong; Yan Song; Litao Ruan
Journal:  Clin Cardiol       Date:  2019-06-07       Impact factor: 2.882

Review 9.  Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective.

Authors:  Nagib Dahdah; Anne Fournier
Journal:  Diagnostics (Basel)       Date:  2013-01-10

10.  Myocardial Strain and Strain Rate in Kawasaki Disease: Range, Recovery, and Relationship to Systemic Inflammation/Coronary Artery Dilation.

Authors:  Benjamin Frank; Jesse Davidson; Suhong Tong; Blake Martin; Heather Heizer; Marsha S Anderson; Mary P Glode; Samuel R Dominguez; Pei-Ni Jone
Journal:  J Clin Exp Cardiolog       Date:  2016-04-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.